Merck & Co (MRK.N) on Friday said quarterly sales of its Keytruda cancer immunotherapy exceeded $1 billion for the first time, but it withdrew an application for European use of the drug in lung cancer, raising questions about future sales. More »
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck’s pipeline and diversifying its portfolio of medicines. REUTERS/Jeff Zelevansky Merck & ... More »
A trader passes by a screen displaying the tickers symbol for Bristol-Myers Squibb on the floor at the New York Stock Exchange, April 25, 2013. REUTERS/Brendan McDermid New data is likely to prompt doctors to abandon Bristol-Myers Squibb’s immunotherapy Opdivo... More »
